We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

Back to rankings

34 hedge funds and large institutions have $3.43M invested in Sophiris Bio, Inc. in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

6% more funds holding

Funds holding: 32 → 34 (+2)

21% less capital invested

Capital invested by funds: $4.35M → $3.43M (-$920K)

23% less call options, than puts

Call options by funds: $181K | Put options by funds: $235K

Holders
34
Holders Change
+2
Holders Change %
+6.25%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
5
Closed
6
Calls
$181K
Puts
$235K
Net Calls
-$54K
Net Calls Change
+$69K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$235K
2
Northern Trust
Northern Trust
Illinois
+$44.4K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$42K
4
Squarepoint
Squarepoint
New York
+$29.9K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$28.7K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$295K
2
Millennium Management
Millennium Management
New York
-$206K
3
Goldman Sachs
Goldman Sachs
New York
-$125K
4
SM
Sabby Management
Florida
-$121K
5
OAM
Oxford Asset Management
United Kingdom
-$55K
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
26
Edge Wealth Management
New York
$4K – – –
Wells Fargo
27
Wells Fargo
California
$4K – – –
FANJ
28
Financial Architects (New Jersey)
New Jersey
$2K – – –
CG
29
Cutler Group
California
$2K +$2.17K +1,000 New
JCM
30
Jacobi Capital Management
Pennsylvania
$1K – – –
FDCDDQ
31
Federation des caisses Desjardins du Quebec
Quebec, Canada
$366 – – –
SM
32
Sabby Management
Florida
– -$121K -55,907 Closed
OAM
33
Oxford Asset Management
United Kingdom
– -$55K -24,065 Closed
JP Morgan Chase
34
JP Morgan Chase
New York
– -$50.7K -23,400 -100%
Citadel Advisors
35
Citadel Advisors
Florida
– -$49K -21,608 Closed
TSS
36
Two Sigma Securities
New York
– -$37K -16,333 Closed
Macquarie Group
37
Macquarie Group
Australia
– -$8K -3,700 Closed
Northwestern Mutual Wealth Management
38
Northwestern Mutual Wealth Management
Wisconsin
– -$1K -400 Closed
Barclays
39
Barclays
United Kingdom
– +$2 +1 New
1832 Asset Management
40
1832 Asset Management
Ontario, Canada
– +$455 +210 New
1
2

SPHS Hedge Fund Activity: Q1 2018 in Review

34 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q1 2018, worth a combined $3.43M — down 21% from $4.35M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SPHS positions and 6 closed out — a net gain of 2 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $235K. The largest seller was Virtu Financial, cutting an estimated $295K.

  • 34 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q1 2018, up from 32 in Q4 2017.
  • Funds reported $3.43M of Sophiris Bio, Inc. stock for Q1 2018, down 21% quarter-over-quarter.
  • 8 funds opened new Sophiris Bio, Inc. positions in Q1 2018 and 6 closed out, a net change of +2 holders.
  • The largest Sophiris Bio, Inc. buyer in Q1 2018 was Vanguard Group, an estimated $235K added.
  • The largest Sophiris Bio, Inc. seller in Q1 2018 was Virtu Financial, an estimated $295K sold.

Based on aggregated 13F filings for Q1 2018.